Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies
James T. Cassidy(University of Liverpool), Ulrich‐Peter Rohr(Roche (Switzerland)), Fairooz F. Kabbinavar(Kaiser Permanente), Leonard B. Saltz(Memorial Sloan Kettering Cancer Center), Herbert I. Hurwitz(Duke Medical Center), Bruce J. Giantonio(Northwestern University)
Cited by 160
Related Papers
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
|The Lancet|2016|4.8k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
|New England Journal of Medicine|2018|3.5k
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
|New England Journal of Medicine|2000|3k
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k